• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Down Over 100 Points; Sidus Space Shares Spike Higher

    1/3/24 2:20:05 PM ET
    $ESPR
    $NMRD
    $SASI
    $SIDU
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $ESPR alert in real time by email

    U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday.

    The Dow traded down 0.52% to 37,518.35 while the NASDAQ fell 0.98% to 14,621.38. The S&P 500 also fell, dropping, 0.61% to 4,713.82.

    Check This Out: How To Earn $500 A Month From Apple Stock Following Tuesday's Slide

     

    Leading and Lagging Sectors

     

    Energy shares rose by 0.8% on Wednesday.

    In trading on Wednesday, real estate shares fell by 1.8%.

     

    Top Headline

     

    The number of job openings fell by 62,000 from the prior month to 8.790 million in November, compared to market estimates of 8.85 million.

     

    Equities Trading UP

     

    Sidus Space, Inc. (NASDAQ:SIDU) shares shot up 62% to $11.32 after it secured a Tier 1 remote sensing license to include Panchromatic (PAN) and Shortwave Infrared (SWIR) imaging capabilities.

    Shares of Trinity Place Holdings Inc. (NYSE:TPHS) got a boost, surging 55% to $0.1774. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024.

    Sigma Additive Solutions, Inc. (NASDAQ:SASI) shares were also up, gaining 47% to $4.2609. Sigma Additive Solutions, announced in an 8-K Filing, the approval of the issuance of the shares of common stock in exchange for all the capital stock of NextTrip Holdings.

     

    Equities Trading DOWN

     

    SoFi Technologies, Inc. (NASDAQ:SOFI) shares dropped 14% to $8.32 after Keefe, Bruyette & Woods downgraded rating on the stock from Market Perform to Underperform and lowered the price target from $7.50 to $6.50.

    Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) were down 21% to $2.2950 after the company announced a $125 million amendment to the collaboration with Japanese pharma company Daiichi Sankyo Co., Ltd.

    Nemaura Medical Inc. (NASDAQ:NMRD) was down, falling 30% to $0.1317. Nemaura Medical's board of directors and management team have made the strategic decision to accept Nasdaq's determination to delist Nemaura Medical and move to the OTC Markets.

    Also Check This Out: Top 3 Industrials Stocks That Could Blast Off In Q1

     

    Commodities

     

    In commodity news, oil traded up 3.3% to $72.72 while gold traded down 1.6% at $2,040.20.

    Silver traded down 3.5% to $23.125 on Wednesday while copper fell 0.4% to $3.8635.

     

    Euro zone

     

    European shares closed lower today. The eurozone’s STOXX 600 fell 0.86%, London’s FTSE 100 fell 0.51% while Spain’s IBEX 35 Index fell 1.26% The German DAX fell 1.38% French CAC 40 fell 1.58% while Italy’s FTSE MIB Index dipped 1.39%.

    German jobless rate rose to 5.9% in December from November's revised reading of 5.8%. The number of people registering as jobless in Spain fell by 1%, reaching 2.71 million for December.

     

    Asia Pacific Markets

     

    Asian markets closed mostly lower on Wednesday, with Hong Kong’s Hang Seng Index falling 0.85% and China’s Shanghai Composite Index gaining 0.17%. India’s S&P BSE Sensex, meanwhile, fell 0.75%.

    The S&P Global Indian manufacturing PMI fell to 54.9 in December from 56.0 in the prior month. Australian CoreLogic Home Value Index increased 0.4% in December versus a 0.6% increase a month ago.

     

    Economics

     

    Mortgage applications in the U.S. declined by 10.7% in the week ending Dec. 29.

    The number of job openings fell by 62,000 from the prior month to 8.790 million in November, compared to market estimates of 8.85 million.

    The ISM Manufacturing PMI rose to 47.4 in December from 46.7 in the prior month, and topping than market estimates of 47.1. However, the recent reading signalled contraction in factory activity for the 14th month.

    Now Read This: Jim Cramer Says Move On From This Energy Stock: 'It's Moved Too Much'

    Get the next $ESPR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ESPR
    $NMRD
    $SASI
    $SIDU

    CompanyDatePrice TargetRatingAnalyst
    SoFi Technologies Inc.
    $SOFI
    4/15/2026Hold
    Argus
    SoFi Technologies Inc.
    $SOFI
    3/19/2026$19.00Equal Weight
    Wells Fargo
    SoFi Technologies Inc.
    $SOFI
    2/9/2026$30.00Mkt Perform → Mkt Outperform
    Citizens
    SoFi Technologies Inc.
    $SOFI
    2/3/2026$31.00Neutral → Overweight
    Analyst
    SoFi Technologies Inc.
    $SOFI
    2/2/2026$36.00 → $33.00Buy
    Needham
    SoFi Technologies Inc.
    $SOFI
    1/6/2026$20.50Underperform
    BofA Securities
    Esperion Therapeutics Inc.
    $ESPR
    11/25/2025$9.00Overweight
    Piper Sandler
    SoFi Technologies Inc.
    $SOFI
    9/10/2025$25.00 → $29.00Buy
    Needham
    More analyst ratings

    $ESPR
    $NMRD
    $SASI
    $SIDU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Noto Anthony bought $500,516 worth of shares (28,900 units at $17.32), increasing direct ownership by 0.25% to 11,704,352 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/17/26 4:05:47 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Chief Executive Officer Noto Anthony bought $1,001,515 worth of shares (56,000 units at $17.88), increasing direct ownership by 0.48% to 11,675,452 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/2/26 3:36:37 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    General Counsel Lavet Robert S bought $105,220 worth of shares (5,000 units at $21.04) (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/6/26 6:18:51 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $ESPR
    $NMRD
    $SASI
    $SIDU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, GBUL, SIPS Keough Kelli sold $187,551 worth of shares (9,742 units at $19.25) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 333,284 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    4/23/26 5:20:13 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Borden William A.

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    4/2/26 7:55:54 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Keough Kelli

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/20/26 6:33:33 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $ESPR
    $NMRD
    $SASI
    $SIDU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Argus initiated coverage on SoFi Technologies

    Argus initiated coverage of SoFi Technologies with a rating of Hold

    4/15/26 8:10:03 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Wells Fargo initiated coverage on SoFi Technologies with a new price target

    Wells Fargo initiated coverage of SoFi Technologies with a rating of Equal Weight and set a new price target of $19.00

    3/19/26 8:27:12 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    SoFi Technologies upgraded by Citizens with a new price target

    Citizens upgraded SoFi Technologies from Mkt Perform to Mkt Outperform and set a new price target of $30.00

    2/9/26 6:58:53 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $ESPR
    $NMRD
    $SASI
    $SIDU
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Esperion Therapeutics Inc.

    SCHEDULE 13G - Esperion Therapeutics, Inc. (0001434868) (Subject)

    4/22/26 3:44:39 PM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B5 filed by Sidus Space Inc.

    424B5 - Sidus Space Inc. (0001879726) (Filer)

    4/20/26 5:20:12 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Sidus Space Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Sidus Space Inc. (0001879726) (Filer)

    4/20/26 5:13:07 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $ESPR
    $NMRD
    $SASI
    $SIDU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

    SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

    11/14/24 7:31:47 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by Esperion Therapeutics Inc.

    SC 13G/A - Esperion Therapeutics, Inc. (0001434868) (Subject)

    11/14/24 8:42:21 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Esperion Therapeutics Inc.

    SC 13G/A - Esperion Therapeutics, Inc. (0001434868) (Subject)

    11/12/24 2:23:13 PM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ESPR
    $NMRD
    $SASI
    $SIDU
    Leadership Updates

    Live Leadership Updates

    View All

    SoFi, Kelsea Ballerini, and CMA Launch Amplify Your Ambitions Contest to Empower America's Next Generation of Emerging Artists

    Emerging artists can win up to $200,000 and take the stage at an exclusive CMA Fest concert, as SoFi helps turn ambitions into financial realities SoFi, the one-stop shop for digital financial services, is launching the "Amplify Your Ambitions" Contest, a nationwide search to discover emerging artists as they pursue their ambitions and advance their careers, in partnership with the Country Music Association (CMA) and multi-platinum songwriter, producer, and author Kelsea Ballerini, a five-time GRAMMY® Award nominee and multiple ACM and CMA Award winner. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414427860/en/SoFi Amplif

    4/15/26 9:00:00 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Sidus Space Appoints Aerospace Executive Kelle Wendling to Board of Directors

    Veteran Space and Defense Leader Brings Three Decades of Government Contracting, ISR, and Space Systems Expertise to Sidus Board CAPE CANAVERAL, Fla., Jan. 5, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced the appointment of accomplished aerospace and defense executive Kelle Wendling to its Board of Directors. Ms. Wendling brings more than three decades of executive leadership and government contracting experience across space systems, Intelligence, Surveillance and Reconnaissance (ISR), and Federal Aviation Administration (FAA) markets.

    1/5/26 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    United Airlines Launches MileagePlus Debit Rewards Card that Earns Miles for Spending and Saving

    This new card allows MileagePlus members to earn miles through everyday purchases and qualifying account balances Available now with no monthly fees with an average daily account balance of $2,000 or greater, MileagePlus members can open the debit rewards card at UnitedDebitRewards.com CHICAGO, Nov. 4, 2025 /PRNewswire/ -- United Airlines today announced a new MileagePlus® Debit Rewards Card that offers cardmembers additional ways to earn miles through spending and saving – designed to make flying the world's largest airline* even more rewarding. As part of the launch, for a l

    11/4/25 8:00:00 AM ET
    $SOFI
    $UAL
    Finance: Consumer Services
    Finance
    Air Freight/Delivery Services
    Consumer Discretionary

    $ESPR
    $NMRD
    $SASI
    $SIDU
    Financials

    Live finance-specific insights

    View All

    Esperion to Report First Quarter 2026 Financial Results on May 7

    ANN ARBOR, Mich., April 23, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced it will report first quarter 2026 financial results before the market opens on Thursday, May 7, 2026. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financial results and provide business updates. A live audio webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days. About Esperion Therapeutics Esperion Therapeutics, Inc. is a commercial-stage biopharmaceutical c

    4/23/26 8:00:00 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The Only Mach 2+ Commercial Fleet in the World Is Now Testing Reusable Hypersonic Space Systems -- and the Pentagon Is Writing the Checks

    Issued on behalf of Starfighters Space, Inc.CAPE CANAVERAL, Fla., April 2, 2026 /CNW/ -- USA News Group News Commentary — The next arms race isn't being fought on the ground. It's being fought at 45,000 feet and Mach 2, in the stratosphere where hypersonic weapons are validated, reusable space systems are tested, and the gap between the United States and its adversaries is either closed or conceded. The Pentagon knows it. Congress knows it. And the capital flowing into the commercial aerospace sector right now reflects exactly that urgency. The U.S. Space Force is operating on a

    4/2/26 2:02:00 PM ET
    $ASTS
    $FJET
    $LUNR
    Telecommunications Equipment
    Consumer Discretionary
    Air Freight/Delivery Services
    Industrial Machinery/Components

    SoFi Schedules Conference Call to Discuss Q1 2026 Results

    SoFi Technologies, Inc. (NASDAQ:SOFI), the one-stop shop for digital financial services, today announced plans to host a conference call to discuss financial and operating results for the first quarter of 2026 on Wednesday, April 29, 2026, at 8 a.m. Eastern Time. SoFi also plans to release its first quarter 2026 results on the investor relations section of its website at https://investors.sofi.com at approximately 7 a.m. Eastern Time on Wednesday, April 29, 2026. Full session details for the conference call and webcast are as follows: CONFERENCE CALL DETAILS – TO DIAL IN BY PHONE To pre-register for this call, please go to the following link (you will then receive your personal dial-in

    4/1/26 8:00:00 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $ESPR
    $NMRD
    $SASI
    $SIDU
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLETOL issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLETOL (SUPPL-13) with active ingredient BEMPEDOIC ACID has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211616, Application Classification: Efficacy

    3/25/24 4:41:29 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ESPR
    $NMRD
    $SASI
    $SIDU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sidus Space Advances its Fortis Next-Generation Command and Data Handling (C&DH) System

    Microchip collaboration enables accelerated, modular, and mission‑scalable OpenVPX architectures for space and defense applications CAPE CANAVERAL, Fla., April 23, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced continued advancements to its Fortis Command and Data Handling (C&DH) platform, a modular 3U OpenVPX system designed to support rapid development, configuration flexibility, and long-term scalability across next-generation space and defense missions. Supported by a strate

    4/23/26 8:31:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Esperion to Report First Quarter 2026 Financial Results on May 7

    ANN ARBOR, Mich., April 23, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced it will report first quarter 2026 financial results before the market opens on Thursday, May 7, 2026. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financial results and provide business updates. A live audio webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days. About Esperion Therapeutics Esperion Therapeutics, Inc. is a commercial-stage biopharmaceutical c

    4/23/26 8:00:00 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SoFi Expands Home Lending to Give Members Greater Access to Home Equity and Support Across Homeownership Journey

    New HELOC experience and national agent network bring members greater access to equity, speed, and confidence in today's housing market SoFi Technologies, Inc. (NASDAQ:SOFI), the one-stop shop for digital financial services, today announced the launch of a new Home Equity Line of Credit (HELOC) experience rolling out to members offering the ability to access their home equity through a seamless, fully digital, end-to-end process directly within the SoFi platform. SoFi also introduced its first Real Estate Advisory Council, convening top agents, including Andrew Jevin (Compass), Kourtney Pulitzer (Sotheby's), and Katie Day (Real Broker), alongside a broader group from top brokerages across

    4/22/26 9:00:00 AM ET
    $SOFI
    Finance: Consumer Services
    Finance